List of Figures
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 10
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Proportion of Acute and Sub-Acute Bursitis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 15
Acute and Sub-Acute Bursitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Acute and Sub-Acute Bursitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Acute and Sub-Acute Bursitis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 19
Acute and Sub-Acute Bursitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Acute and Sub-Acute Bursitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
GlobalData Methodology 50


List of Tables
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 10
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Acute and Sub-Acute Bursitis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 16
Acute and Sub-Acute Bursitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Acute and Sub-Acute Bursitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Acute and Sub-Acute Bursitis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 20
Acute and Sub-Acute Bursitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Acute and Sub-Acute Bursitis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Acute and Sub-Acute Bursitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Acute and Sub-Acute Bursitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30